Study finds drug approved to treat metabolic acidosis intravenously might serve as an aerosol to reduce airway surface liquid acidity in cystic fibrosis.
Study finds drug approved to treat metabolic acidosis intravenously might serve as an aerosol to reduce airway surface liquid acidity in cystic fibrosis.